From Casetext: Smarter Legal Research

Otsuka Pharm. Co. v. Sandoz, Inc.

United States Court of Appeals for the Federal Circuit
Jun 13, 2012
Appeal No. 2011-1126 (Fed. Cir. Jun. 13, 2012)

Opinion

Appeal No. 2011-1126 Appeal No. 2011-1127

06-13-2012

OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff-Appellee, v. SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON BV, SYNTHON HOLDINGS BV, SYNTHON LABORATORIES, INC., and SYNTHON PHARMACEUTICALS, INC., Defendants, and APOTEX INC. and APOTEX CORP., Defendants-Appellants, and TEVA PHARMACEUTICALS USA, INC., BARR LABORATORIES, INC., and BARR PHARMACEUTICALS, INC., Defendants-Appellants.


ERRATUM


Precedential Opinion

The following change has been made:

Page 21, line 4, "marketed" has been changed to -- promising--.


Summaries of

Otsuka Pharm. Co. v. Sandoz, Inc.

United States Court of Appeals for the Federal Circuit
Jun 13, 2012
Appeal No. 2011-1126 (Fed. Cir. Jun. 13, 2012)
Case details for

Otsuka Pharm. Co. v. Sandoz, Inc.

Case Details

Full title:OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff-Appellee, v. SANDOZ, INC., SUN…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jun 13, 2012

Citations

Appeal No. 2011-1126 (Fed. Cir. Jun. 13, 2012)